Follow the people · Insider

JO

John Oyler

Insider · Chief Executive Officer · ONC

John Oyler files insider transactions with the SEC as a chief executive officer of BeOne Medicines (ONC). We hold 15 disclosed purchases and sales filed since 9 February 2016, 14 of them in the last 90 days.

  • Files forONC
  • Disclosed buys and sells15 in all, 14 in the last 90 days
  • Last disclosure12 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 6 June 202512 August 2026Chief Executive Officer · BeOne Medicines (ONC)171 Form 4 lines · source: SEC Form 4
  • Filed 8 February 20169 May 2025Chief Executive Officer · BeiGene (BGNE)679 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.